Patent: 9,434,785

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,434,785

Title:	Anti-human OX40L antibodies and methods of treating graft versus host disease with the same
Abstract:	The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
Inventor(s):	Bland-Ward; Philip (Cambridge, GB), Campbell; Jamie (Cambridge, GB), Holmes; Steve (Cambridge, GB), Kirby; Ian (Cambridge, GB), Kosmac; Miha (Cambridge, GB), Kean; Leslie Susan (Seattle, WA), Tkachev; Victor (Seattle, WA)
Assignee:	Kymab Limited (Cambridge, GB)
Application Number:	14/935,937
Patent Claims:	see list of patent claims

Details for Patent 9,434,785

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	RITUXAN	rituximab	Injection	103705	1997-11-26	⤷ Try it Free	2035-09-09
Idec Pharmaceuticals Corp.	RITUXAN	rituximab	Injection	103737	2002-02-19	⤷ Try it Free	2035-09-09
Hoffmann-la Roche Inc.	ZENAPAX	daclizumab	Injection	103749	1997-12-10	⤷ Try it Free	2035-09-09
Janssen Biotech, Inc.	REMICADE	infliximab	For Injection	103772	1998-08-24	⤷ Try it Free	2035-09-09
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.